FindTrial
Sign In

HPV prevalence and type distribution in cervical infection, cervical intraepithelial lesions and cervical cancer in Indian Women

Prevalence, Genotype Distribution of HPV in Cervical Infection, and attribution of HPV types to Cervical Intraepithelial Neoplasia and Cervical Cancer in Indian Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/09/003986
Enrollment
2000
Registered
2013-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HPV infection, Cervical intraepithelial neoplasia and Cervical cancer

Interventions

None listed

Sponsors

Shantha Biotechnics Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Adult women aged 18 â?? 60 years, • With or without history of cervical intraepithelial neoplasia lesion or Cervical cancer; • Willing to give Informed consent

Exclusion criteria

Exclusion criteria: • Subject is pregnant • Previous vaccination against HPV

Design outcomes

Primary

MeasureTime frame
Prevalence of specific HPV types for each cervical pathology statusTimepoint: Upon subject enrollment in the study (visit 1; single time point)—

Secondary

MeasureTime frame
Attribution rates of specific HPV types for each cervical pathology statusTimepoint: Upon subject enrollment in the study(visit 1; single time point)—

Countries

India

Contacts

Public ContactDr Mandeep Singh Dhingra

Shantha Biotechnics Limited

DrMandeep@shanthabiotech.co.in040-66301000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026